CARING AMBASSADORS

Empowering People to be Ambassadors of their Own Health Since 1997.

LUNG CANCER PROGRAM


Weekly News

Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week.  Topics include all stories related to lung cancer as well as personal stories and events.

Week ending May 3, 2015

Cancer camaraderie: Supporting the fight

“Bonnie Neel’s eyes welled with tears as she finished talking about her experience with lung cancer last Wednesday. She is surviving. The 65-year-old Hideaway resident was diagnosed with stage 4 lung cancer in 2012 and now she’s “close to remission.”

OUR GOOD DEEDS: Band reunites to raise money for member fighting cancer

“Once a band, always a band; once a band member, always a band member.”

Worse survival after lung cancer surgery for residents of poor neighborhoods

(Reuters Health) – “Residents of low-income neighborhoods with few high school graduates may be more likely to die after lung cancer surgery than more affluent patients, a U.S. study finds.”

Drug tested in Charlotte proves effective for lung cancer patients

“Charlotte researchers and patients participated in a clinical trial that has demonstrated the effectiveness of targeted gene therapy for treating advanced lung cancer.”

Two new lung cancer meds show promise in advanced disease

“In one study, researchers tested the drug AZD9291. They found that among 127 patients with a T790M mutation, the response rate was 61 percent. Most patients went at least six months with no cancer progression, and half went about 10 months or longer. That second figure is similar to what’s seen with Tarceva (erlotinib), one of the first-line epidermal growth factor receptor (EGFR) inhibitors, Pasi Janne, M.D., Ph.D., lead researcher on the study, told HealthDay. Janne is an oncologist at the Dana-Farber Cancer Institute in Boston.”

Keynote 24 study explores investigational approach to treating lung cancer

“Lung cancer impacts the lives of millions of people worldwide. In nearly 40 percent of people diagnosed with lung cancer, it has metastasized, or spread to other areas of the body, making it difficult to treat. Immunotherapy is a type of therapy that uses the body’s own immune system to help fight cancer. Immunotherapy may help the body’s immune system target cancer cells.”

Rociletinib For EGFR Lung Cancer: Phase I/II Trial Results

“The investigational anti-cancer agent rociletinib (CO-1686) has received the new FDA ‘Breakthrough Status’ designation, developed to accelerate the approval process for very promising new medical treatments.”

Lower Paxton lung cancer survivor warns about radon

LOWER PAXTON TOWNSHIP—“Jim Sudhalter has lived in his Lower Paxton Township home for 45 years. The 74-year-old never thought the home he was building memories in could also be causing him harm.”

 

 

Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)